NCT02507544 A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT02455505 Identifying Family Members in Need of Support While Caregiving and After Loss Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02432612 A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer Status WITHDRAWN Phase PHASE1
NCT02423954 Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) Status TERMINATED Phase PHASE1/PHASE2
NCT02418624 Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer Status COMPLETED Phase PHASE1
NCT02407990 Study of the Safety, Pharmacokinetics and Antitumor Activities of BGB-A317 in Participants With Advanced Tumors Status COMPLETED Phase PHASE1
NCT02383368 A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma Status COMPLETED Phase PHASE1
NCT02383212 Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT02357108 Message: Study of Patients' Perception of Physician's Compassion Status COMPLETED Phase NA
NCT02341625 A Study of BMS-986148 in Patients With Select Advanced Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT02331251 Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) Status TERMINATED Phase PHASE1/PHASE2
NCT02318901 Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT02261051 Symptom Management, Quality of Life and Satisfaction With Care for Advanced Stage Cancers - Control Arm Status WITHDRAWN Phase N/A
NCT02245204 Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers Status COMPLETED Phase PHASE1
NCT02219711 Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer Status COMPLETED Phase PHASE1